Day: March 24, 2020

CLR 131 – A New Approach in Multiple Myeloma Treatment

CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head & neck cancers by Cellectar Biosciences. It works by delivering a radioactive, toxic compound directly to tumor…